On June 14 and 15, 2022, the Federal Trade Commission (FTC) and Department of Justice Antitrust Division (DOJ) hosted a workshop entitled "The Future of Pharmaceuticals.
Responding to a significant increase in recent merger and acquisition activity and concern about the effects of “merger driven consolidation across markets,” leadership at the.